ADAR1 Capital
ADAR1 Capital is a Hedge Fund firm.
ADAR1 Capital Management is a biotechnology and healthcare-focused hedge fund managing over $1.3B AUM, with investments in clinical-stage biotechs and notable exits like Evommune.
- AUM
- $1.4B
- Portfolio Companies
- 5
- Recorded investments
- 5
- Latest recorded investment
- Apr 2026
- Geographic Focus
- United States
Example request
curl "https://indexed.vc/api/v1/investors/adar1-capital?depth=slim" -H "X-API-Key: YOUR_API_KEY"Indexed holds 5 portfolio companies and 5 funding rounds for this investor. to use credits for reveals, or explore the API.
Overview
Indexed has recorded 5 investments for ADAR1 Capital. Its portfolio includes Acumen Pharmaceuticals, Kalaris Therapeutics and Fractyl Health. Focus areas include Biotech and Healthcare.
Portfolio5
Co-investors24
Sign up to view co-investors
Up to 24 co-investors shown
Venture Capital ×15 · Hedge Fund ×3 · Family Office ×2
Recorded investments5
Sign up to view investment history
Create a free account with 25 free credits every month, no card needed, to unlock deal history, amounts, and round details.
Your firm? Embed this profile
Add the live badge to your site — it stays current as your portfolio data updates.
<a href="https://indexed.vc/investors/adar1-capital"><img src="https://indexed.vc/api/badge/investor/adar1-capital" alt="ADAR1 Capital on Indexed.vc" width="260" height="76" /></a>
